The Patient Activation Measure® (PAM®) Assessment to be Incorporated into Select CMS Alternative Payment Models
illi News/10032398

PORTLAND, Ore. - illiNews -- Insignia Health has been awarded a contract with the Centers for Medicare and Medicaid Services (CMS) to incorporate the Patient Activation Measure^® (PAM^®), plus a host of integrated solutions and services, to support up to five million beneficiaries.

As authorized by the Affordable Care Act, the Center for Medicare Medicaid Innovation (CMMI) develops Alternative Payment Models (APMs) aimed at achieving better individual healthcare, improved population health, and lower costs through improvements in care delivery across the United States.

To help advance its mission, CMMI has selected the Patient Activation Measure from Insignia Health to support up to five APMs with strategies to reduce cost and improve health outcomes.  Participating models will utilize PAM to measure a patient's ability to manage their health and healthcare, and to assess change over time.

More on illi News

• Eagle Lasers USA Launches New Website to Empower American Metal Fabricators with Next-Generation Fiber Laser Cutting Solutions
• White Glove Restoration Sends "Help in Boxes" to Support Communities in Ghana
• The Rise of Reverse Mortgage Confusion: What Older Homeowners Need to Know Before Signing
• NASA Agreements, New Ocean Exploration Applications Added to Partnerships with Defiant Space Corp and Emtel Energy USA for Solar Tech Leader: $ASTI
• Mayor Brandon Johnson Statement on the Ruling in the Lawsuit Against President Trump's National Guard Deployment in Chicago

Endorsed by the National Quality Forum (NQF) as a performance measure, PAM is also used to guide resource allocation and patient support based upon a patient's self-management ability or activation level.  Patients with lower activation struggle with self-management and utilize significantly more care when compared to patients with higher activation, including higher rates of emergency department visits, hospital readmissions, and use of ambulatory care sensitive (ACS) services.

"We are excited to be working with CMS at the forefront of value-based innovation to achieve improved health outcomes through the gains in self-management that we know patients can achieve," said Chris Delaney, CEO of Insignia Health.  "Measuring patient activation with PAM has proven to be a key vital sign backed by more than a decade of evidence showing that patients low in activation, when supported appropriately, realize the greatest gains in activation and improved health outcomes."

More on illi News

• Chic and Secure: The Blue Luna Debuts Stylish Keychains with Purpose
• BEC Technologies Showcases Leadership in Private Broadband Ecosystem with Inclusion in UTC's Ecosystem Summary Report
• $500,000 in Stock Dividend for Shareholders in 2025 Sweetens The Pot on Success of Becoming Debt Free with No Convertible Notes or Warrants for $IQST
• Getting Your Pond Ready for Winter - Expert Tips from Midwest Pond Features & Landscape
• Aissist.io Launches Hybrid AI Workforce to Solve AI Pilot Failure for Customer Support Automation

About Insignia Health: Insignia Health is the global provider of PAM-based solutions that strengthen the identification of prospective health risk, and guide improved resource allocation and patient support.  The Patient Activation Measure^® (PAM^®) is a predictive powerhouse backed by over 15 years of health activation research and insight gained from supporting health systems, hospitals, insurers, life science companies and government health agencies around the world. The company's products and services help organizations better identify patients at risk for poor health outcomes and then tailor care programs and support based upon a patient's level of activation. Insignia Health is headquartered in Portland, Oregon. Visit www.insigniahealth.com to learn more.